Author:
Hashan Hajed,Aljuffali Ibrahim,Patel Prisha,Walker Stuart
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference14 articles.
1. Alsager SSN, Hashan H, Walker S. Evaluation of the regulatory review system in Saudi Arabia. Pharm Med. 2015;29:93–103.
2. Business monitor International. Research and Markets. Saudi Arabia pharmaceuticals and healthcare report Q3 2015. http://www.fastmr.com/prod/1013231_saudi_arabia_pharmaceuticals.aspx . Accessed July 29, 2015.
3. Al-Jazairi AS, Al-Qadheeb N, Ajlan A. Pharmacoeconomic analysis in Saudi Arabia: an overdue agenda item for action. Ann Saudi Med. 2011;31:335–41.
4. The Cooperation Council for the Arab States of the Gulf. http://www.gcc-sg.org/eng/ . Accessed 27 July 2015.
5. McAuslane N, Cone M, Collins J, Walker S. Emerging markets and emerging agencies: a comparative study of how key regulatory agencies in Asia, Latin America, the Middle East and Africa are developing regulatory processes and review models for new medicinal products. Drug Info J. 2009;43:349–59.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献